At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Medtronic Deep Brain Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)
In Brief
A clinical study evaluating Medtronic Deep Brain Stimulation for Mesial Temporal Lobe Epilepsy. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The primary aim of the current proposal is to evaluate safety and tolerability, in terms of neuropsychological effects of low frequency electrical stimulation of the fornix (LFSF) in participants with medically-intractable Mesial Temporal Lobe Epilepsy. Secondary aims include evaluation of psychiatric changes, seizure frequency, and quality of life during LFSF.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMesial Temporal Lobe Epilepsy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedMar 2015
Primary CompletionJan 2018
Study CompletionJan 2019
TodayJul 2026
First PostedMar 9, 2015
Enrollment StartDec 1, 2013
Primary CompletionJan 1, 2018
Study CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 11.3 years ago
Interventions
Medtronic Deep Brain Stimulationdevice